At a glance
- Originator Taisho Pharmaceutical
- Class Anti-ischaemics; Antihypertensives; Ischaemic heart disorder therapies; Vasodilators
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Heart failure; Hypertension
Most Recent Events
- 22 May 2001 Discontinued-Preclinical for Angina pectoris in Japan (Unknown route)
- 22 May 2001 Discontinued-Preclinical for Heart failure in Japan (Unknown route)
- 22 May 2001 Discontinued-Preclinical for Hypertension in Japan (Unknown route)